De Schepper J, Smitz J, Rosseneu S, Bollen P, Louis O
Department of Pediatrics, Free University of Brussels, Belgium.
Horm Res. 1998;50(4):193-6. doi: 10.1159/000023273.
To detect early abnormalities in bone mineralization, the lumbar spine bone mineral density (BMD) of diabetic children with a diabetes onset of less than 5 years and treated with a similar insulin treatment scheme was measured at the level of the lumbar spine by dual-energy X-ray absorptiometry (DEXA), a most sensitive technique for detecting osteopenia in children. Fifteen male and 8 female children and adolescents (mean age +/- SD: 12.5+/-3.7 years), 1-5 years after the clinical onset of their diabetes, were studied. Measurements of the lumbar spine (L1-L4) BMD, expressed in gHA/cm2 and as a z-score for age, were performed with a commercial DEXA apparatus (Hologic QDR 1000 W, Hologic Inc., Waltham, USA). Calcium-phosphorus metabolism was studied by measuring the circulating levels of calcium, phosphorus, alkaline phosphatase, osteocalcin, 25-OH-vitamin D and parathyroid hormone and the urinary excretion of calcium and phosphorus. The mean BMD of the studied group was 0.75 (0.16) gHA/cm2 giving a mean z-score of -0.31+/-0.95. Only 1 of the patients had a BMD lower than -2 SD. No sex difference in BMD z-score existed. BMD SD was positively correlated with height SD (R = 0.56, p < 0.005), but not with the age of the patients, the duration of the disease, the degree of metabolic control or the studied parameters of the calcium-phosphorus metabolism. In conclusion, diabetic children have a normal lumbar spine BMD during the first years of the disease, when a good metabolic control and no abnormalities in the calcium-phosphorus metabolism are present. As in normal children, areal BMD by DEXA is highly dependent on the body height, necessitating corrections if abnormalities in skeletal growth or pubertal development exist.
为检测骨矿化的早期异常情况,采用双能X线吸收法(DEXA),这是检测儿童骨质减少最敏感的技术,在腰椎水平测量糖尿病病程小于5年且采用相似胰岛素治疗方案的糖尿病儿童的腰椎骨密度(BMD)。研究了15名男性和8名女性儿童及青少年(平均年龄±标准差:12.5±3.7岁),他们在糖尿病临床发病后1 - 5年。使用商用DEXA仪器(美国沃尔瑟姆市Hologic公司的Hologic QDR 1000 W)测量腰椎(L1 - L4)的骨密度,以gHA/cm²表示并作为年龄的z值。通过测量循环中的钙、磷、碱性磷酸酶、骨钙素、25 - 羟基维生素D和甲状旁腺激素水平以及钙和磷的尿排泄量来研究钙磷代谢。研究组的平均骨密度为0.75(0.16)gHA/cm²,平均z值为 - 0.31±0.95。只有1名患者的骨密度低于 - 2标准差。骨密度z值不存在性别差异。骨密度标准差与身高标准差呈正相关(R = 0.56,p < 0.005),但与患者年龄、病程、代谢控制程度或钙磷代谢的研究参数无关。总之,糖尿病儿童在疾病的最初几年腰椎骨密度正常,此时代谢控制良好且钙磷代谢无异常。与正常儿童一样,DEXA测量的面积骨密度高度依赖于身高,如果骨骼生长或青春期发育存在异常则需要进行校正。